Journal of Clinical Pharmacy and Therapeutics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Retraction
‘Influence of genetic variants of IDH1, IDH2, TET2 and DNMT3A on cytarabine cytotoxicity in different populations’ by Y. Wang & J. K. Lamba1The above article from the Journal of Clinical Pharmacy and Therapeutics, published online on 21 November 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted following discussions with the authors, the Journal Editors and John Wiley & Sons Ltd. The Retraction has been agreed as this paper was submitted under the joint names of Yan Wang, Jatinder K. Lamba and a third co‐author. After acceptance of the paper, Dr Wang wrote to the EiC asking for the nam...
Source: Journal of Clinical Pharmacy and Therapeutics - January 14, 2018 Category: Drugs & Pharmacology Tags: RETRACTION Source Type: research

Retraction
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 312-312, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - January 13, 2018 Category: Drugs & Pharmacology Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 312-312, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - January 13, 2018 Category: Drugs & Pharmacology Source Type: research

Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations
Summary What is known and objectiveOxaliplatin in combination with fluorouracil and folinic acid is one of the preferred chemotherapeutic options in the treatment of metastatic rectum cancer. However, oxaliplatin is contraindicated in patients with a creatinine clearance <30 mL/min and dosing guidelines in patients on haemodialysis have not been established. Case summaryA 77‐year‐old haemodialysis patient with metastatic rectum cancer was treated with FOLFOX and bevacizumab (oxaliplatin 70 mg/m2, folinic acid 200 mg/m2, 5‐FU 340 mg/m2 bolus and 2040 mg/m2 continuous infusion during 44 hours and bevacizumab 5...
Source: Journal of Clinical Pharmacy and Therapeutics - January 6, 2018 Category: Drugs & Pharmacology Authors: I. R. F. Berlo – van de Laar, W. J. Brummelhuis, A. L. T. Imholz, J. H. Schellens, A. D. R. Huitema, F. G. A. Jansman Tags: CASE REPORT Source Type: research

Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - January 5, 2018 Category: Drugs & Pharmacology Authors: I. R. F.vanBerlo – van de Laar PharmD , W. J.Brummelhuis MD, PhD , A. L. T.Imholz MD, PhD , J. H.Schellens PharmD , A. D. R.Huitema PharmD , F. G. A.Jansman PharmD, PhD Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics, Ahead of Print. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - January 5, 2018 Category: Drugs & Pharmacology Source Type: research

Issue information
(Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - January 2, 2018 Category: Drugs & Pharmacology Tags: ISSUE INFORMATION Source Type: research

Association of CYP2C9*3 with phenytoin ‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta‐analysis
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 3, Page 408-413, June 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - December 23, 2017 Category: Drugs & Pharmacology Authors: X. Wu MS , W. Liu MS , W. Zhou MS Source Type: research

Association of CYP2C9*3 with phenytoin ‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta‐analysis
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - December 23, 2017 Category: Drugs & Pharmacology Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics, Ahead of Print. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - December 23, 2017 Category: Drugs & Pharmacology Source Type: research

Marked efficacy of combined three ‐drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - December 18, 2017 Category: Drugs & Pharmacology Authors: M. Morimoto PhD , S. Shimakawa PhD , T. Hashimoto PhD , T. Kitaoka MS , S. Kyotani PhD Source Type: research

Population pharmacokinetics of levetiracetam in neonates with seizures
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 3, Page 422-429, June 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - December 18, 2017 Category: Drugs & Pharmacology Authors: V. Lima ‐Rogel MD , E. J. López‐López MSc , S. E. Medellín‐Garibay PhD , L. M. Gómez‐Ruiz MD , C. Romero‐Méndez BPS , R. C. Milán‐Segovia PhD , S. Romano‐Moreno PhD Source Type: research

Population pharmacokinetics of levetiracetam in neonates with seizures
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - December 18, 2017 Category: Drugs & Pharmacology Source Type: research